Gsk India Annual Report 2025 – 32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 . Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, .

Gsk India Annual Report 2025

Source : www.linkedin.com

EX 15.2

Source : www.sec.gov

One of the Leading Pharmaceutical Companies in India | GSK India

Source : india-pharma.gsk.com

2023 Annual Report

Source : www.gsk.com

Razia Sayed Head of Business Development for Global Health GSK

Source : sg.linkedin.com

Diversity, equity and inclusion | GSK India

Source : india-pharma.gsk.com

GSK delivers strong 2023 performance and upgrades growth outlooks

Source : www.gsk.com

clavulanate potassium market size and forecast Size, Trends and

Source : www.marketresearchintellect.com

Environment | GSK

Source : www.gsk.com

pantoprazole market size and forecast Size, Trends and Forecast

Source : www.marketresearchintellect.com

Gsk India Annual Report 2025 Praveen D’sa on LinkedIn: Proud to be a part of the GSK family.: GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of with regional and sales hubs across India. The Company is engaged interalia in the business of manufacturing distributing and trading in . View upcoming earnings forecasts and in-depth analysis of company forecasts. .